<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02936297</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#16D.244</org_study_id>
    <nct_id>NCT02936297</nct_id>
  </id_info>
  <brief_title>Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study</brief_title>
  <acronym>NCGS</acronym>
  <official_title>Quantitative Measurement of Stool and Urine Gluten Immunogenic Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-celiac gluten sensitivity (NCGS) is an emerging clinical entity defined as the presence
      of intestinal and/or extraintestinal symptoms induced by the ingestion or gluten and relieved
      by a gluten free diet (GFD) in patients without celiac disease or wheat allergy. The
      pathologic mechanism of the disorder is unknown, and there are no known biomarkers or
      associated histopathologic findings. In this prospective, randomized controlled trail, we are
      investigating the utility of patient reported symptom questionnaires, as well as stool gluten
      and urine quantification tools in patients with NCGS and healthy controls.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient estimated gluten intake after administration of gluten compared to baseline level on GFD, using the Celiac Dietary Adherence Test (CDAT)</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NCGS symptoms, using the Celiac Symptom Index (CSI)10 after administration of gluten compared to baseline level on GFD</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool gluten immunogenic peptides (GIP) level after administration of gluten compared to baseline level on GFD.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine gluten immunogenic peptides (GIP) level after administration of gluten compared to baseline level on GFD</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Estimation of Gluten Intake captured via (PEGI) questionnaire</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Non Celiac Gluten Sensitivity</condition>
  <arm_group>
    <arm_group_label>Lactose free placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Lactose free placebo pill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose Gluten (0.5g)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low dose gluten pill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose Gluten (2.0g)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High dose gluten pill</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High dose Gluten</intervention_name>
    <arm_group_label>High Dose Gluten (2.0g)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low dose Gluten</intervention_name>
    <arm_group_label>Low dose Gluten (0.5g)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactose free placebo</intervention_name>
    <arm_group_label>Lactose free placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria include

          -  Patients &gt; 18 years of age

          -  Patients willing to maintain gluten free diet for 6 weeks

        Exclusion Criteria (NCGS):

          -  Patients &lt; 18 years of age

          -  Patients with positive serology suggestive of celiac disease and/or biopsy-proven
             celiac disease and/or Human leukocyte antigen (HLA) DQ2 or DQ8 positivity.

          -  Patients with a diagnosis of inflammatory bowel disease

          -  Patients with a diagnosis of acute gastroenteritis

          -  Patients who are pregnant

          -  Type 1 Diabetes Mellitus

        Exclusion criteria (healthy controls):

          -  NCGS

          -  Celiac disease

          -  Inflammatory bowel disease

          -  Irritable bowel syndrome

          -  Acute gastroenteritis

          -  Patients who are pregnant

          -  Type 1 Diabetes Mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael J Matthews</last_name>
    <phone>215-503-2545</phone>
    <email>michael.matthews@jefferson.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael J Matthews</last_name>
      <phone>215-503-2545</phone>
      <email>michael.matthews@jefferson.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2016</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

